Loading...

ONCOTELIC THERAPEUTICS INC Company Mergers 8-K Filing

NCTL

ONCOTELIC THERAPEUTICS INC

()

2026 8-K

Joint Development Agreement

Product Launch Announcement

Research Presentation

Financing Agreement

Stock Agreement Details

Milestone Amendment

Contract Amendment

Funding Agreement Completed

Debt Financing Agreement

Access to Research Tools

Investment Offering Details

Investor Presentation Update

Equity Offerings

Presentation Announcement

External Links:

On March 31, 2026, Oncotelic Therapeutics, Inc. signed a Joint Development, Manufacturing, and Licensing Agreement with TechForce Robotics to develop AI-enabled robotic systems for pharmaceutical manufacturing. The partnership will include shared development costs and revenue-sharing agreements.

AI Assistant

ONCOTELIC THERAPEUTICS INC

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.